Skip to main content
ArticleOPEN ACCESS

20-HETE in acute kidney injury

Kidney International
DOI: 10.1038/ki.2010.396
19Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ischemia/reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) that is associated with a patient mortality of up to 50%. Currently there are not effective pharmacologic therapies for AKI. This Commentary highlights recent evidence indicating that 20-HETE plays an important role in IRI and that drugs that target this pathway have potential as therapeutic agents for AKI. © 2011 International Society of Nephrology.

Cite

CITATION STYLE

APA

Roman, R. J., Akbulut, T., Park, F., & Regner, K. R. (2011). 20-HETE in acute kidney injury. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2010.396

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free